FBIO $0.50 -3 drugs nearing FDA approval expected during 2024 and has many others in Phase 3 trials (see slide below) ..FBIO likely one oif the most attractive smallcap stock in the biotech area .
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.